CRISPR screen in mechanism and target discovery for cancer immunotherapy
Dan Liu(Machine Intelligence Research Institute), Ming Shi(Southwest Jiaotong University), Xiyue Xu(Anhui Agricultural University), Anqun Tang(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College), Xuan Zhao(People's Hospital of Xinjiang Uygur Autonomous Region), Shuci Liu(Xuzhou Medical College), Wen Ma(Xuzhou Medical College), Li Zha(Xuzhou Medical College)
Cited by 43
Related Papers
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|405
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136